BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.140
-0.020 (-1.72%)
At close: Apr 28, 2026, 4:00 PM EDT
1.160
+0.020 (1.74%)
After-hours: Apr 28, 2026, 4:54 PM EDT

BioCardia Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Revenue
-0.060.481.351.02
Upgrade
Revenue Growth (YoY)
--87.84%-64.72%33.20%600.00%
Upgrade
Cost of Revenue
4.964.397.738.838.56
Upgrade
Gross Profit
-4.96-4.33-7.25-7.48-7.54
Upgrade
Selling, General & Admin
3.323.674.44.425.09
Upgrade
Operating Expenses
3.323.674.44.425.09
Upgrade
Operating Income
-8.28-8-11.64-11.9-12.63
Upgrade
Interest & Investment Income
0.050.060.07--
Upgrade
Other Non Operating Income (Expenses)
----0.010.01
Upgrade
EBT Excluding Unusual Items
-8.23-7.95-11.57-11.91-12.62
Upgrade
Pretax Income
-8.23-7.95-11.57-11.91-12.62
Upgrade
Net Income
-8.23-7.95-11.57-11.91-12.62
Upgrade
Net Income to Common
-8.23-7.95-11.57-11.91-12.62
Upgrade
Shares Outstanding (Basic)
73111
Upgrade
Shares Outstanding (Diluted)
73111
Upgrade
Shares Change (YoY)
142.98%94.32%19.52%4.75%67.19%
Upgrade
EPS (Basic)
-1.23-2.90-8.19-10.08-11.19
Upgrade
EPS (Diluted)
-1.23-2.90-8.19-10.08-11.19
Upgrade
Free Cash Flow
-7.44-7.89-9.99-10.63-10.48
Upgrade
Free Cash Flow Per Share
-1.12-2.88-7.07-9.00-9.29
Upgrade
Operating Margin
--13794.83%-2441.09%-880.25%-1244.34%
Upgrade
Profit Margin
--13700.00%-2425.79%-880.70%-1243.64%
Upgrade
Free Cash Flow Margin
--13606.90%-2093.50%-786.32%-1032.71%
Upgrade
EBITDA
-8.25-7.93-11.56-11.82-12.57
Upgrade
D&A For EBITDA
0.020.070.080.080.06
Upgrade
EBIT
-8.28-8-11.64-11.9-12.63
Upgrade
Revenue as Reported
---1.351.02
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.